Triumvira a, Canadian US, post series A, biotech company, working on the development of a new targeted cancer therapies. The core technology is focused on the genetic engineering of immune cells isolated from patients. This process then enables these immune cells to recognise cancer cells that otherwise are invisible to the immune system. These therapies […]
Read More